Literature DB >> 32929640

Head-to-head comparison of multiple cardiovascular magnetic resonance techniques for the detection and quantification of intramyocardial haemorrhage in patients with ST-elevation myocardial infarction.

Anna Giulia Pavon1,2,3, Georgios Georgiopoulos4, Gabriella Vincenti1,2, Olivier Muller2, Pierre Monney1,2,5, Gregoire Berchier6, Chiara Cirillo7, Eric Eeckhout2, Juerg Schwitter1,2,5, Pier Giorgio Masci1,2,7.   

Abstract

OBJECTIVES: T2*-weighted (T2*w) is deemed as a reference standard for post-infarction intramyocardial haemorrhage (IMH). However, high proportion of T2* images is affected by off-resonance artefacts hampering image interpretation. Diagnostic accuracy and precision of alternative techniques for IMH diagnosis and quantification have been seldomly investigated. METHODS AND
RESULTS: Between April 2016 and May 2017, 50 ST-segment elevation myocardial infarction patients (66% male, 57 ± 17 years) and 15 healthy controls (60% male, 58 ± 13) were consecutively enrolled. Subjects underwent head-to-head comparison of single mid-infarct slice acquired on black-blood T2-weighted short-TI-inversion recovery (T2w-STIR), bright-blood T2prep-steady-state-free precession (T2prep-SSFP), and T2/T1 maps for IMH diagnosis and quantification against T2*w. All images were graded for quality (grade 1: very poor; grade 4: excellent) and diagnostic confidence (Likert scale, 1: very unsure and 5: highly confident). Reduced relaxation time/hypointense region (hypocore) embedded in infarct-related oedema on T2 map, T1 map, and T2w-STIR had the best overall diagnostic accuracy (per-subject: 91%, 86%, and 86%, respectively; per segment: 95%, 93%, and 93%, respectively). By mixed-effects analysis, image quality, and diagnostic confidence were higher for T2 map and T1 maps than T2*w (p < 0.05 for both scores). For IMH quantification, hypocore on T2 map and T1 map strongly correlated (Spearman's r > 0.7, p < 0.001 for both) with IMH extent on T2*w and presented an overall excellent agreement on Bland-Altman analysis. By linear mixed model analysis, absolute hypocore size did not differ among T1-, T2 map, and T2*w. T2/T1 maps had the best intra- and inter-observer reproducibility among CMR techniques.
CONCLUSION: Hypocore on T2/T1 map is the best alternative technique to T2*w for diagnosing and quantifying IMH in post-STEMI patients. KEY POINT: • Mapping techniques are the best alternatives for diagnosing post-infarction intramyocardial haemorrhage. • Mapping techniques are valuable tools for imaging intramyocardial haemorrhage.

Entities:  

Keywords:  Magnetic resonance imaging; Myocardial infarction; Myocardial ischemic reperfusion injury

Mesh:

Year:  2020        PMID: 32929640      PMCID: PMC7880961          DOI: 10.1007/s00330-020-07254-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  30 in total

1.  Reperfusion haemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular remodelling and markers of late arrhythmic risk.

Authors:  Adam N Mather; Timothy A Fairbairn; Stephen G Ball; John P Greenwood; Sven Plein
Journal:  Heart       Date:  2010-11-04       Impact factor: 5.994

2.  Long-Term Incremental Prognostic Value of Cardiovascular Magnetic Resonance After ST-Segment Elevation Myocardial Infarction: A Study of the Collaborative Registry on CMR in STEMI.

Authors:  Rolf Symons; Gianluca Pontone; Juerg Schwitter; Marco Francone; Juan Fernando Iglesias; Andrea Barison; Jaroslaw Zalewski; Laura de Luca; Sophie Degrauwe; Piet Claus; Marco Guglielmo; Jadwiga Nessler; Iacopo Carbone; Giovanni Ferro; Monika Durak; Paolo Magistrelli; Alfonso Lo Presti; Giovanni Donato Aquaro; Eric Eeckhout; Christian Roguelov; Daniele Andreini; Pierre Vogt; Andrea Igoren Guaricci; Saima Mushtaq; Valentina Lorenzoni; Olivier Muller; Walter Desmet; Luciano Agati; Stefan Janssens; Jan Bogaert; Pier Giorgio Masci
Journal:  JACC Cardiovasc Imaging       Date:  2017-08-16

3.  Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction.

Authors:  Martin Ugander; Paul S Bagi; Abiola J Oki; Billy Chen; Li-Yueh Hsu; Anthony H Aletras; Saurabh Shah; Andreas Greiser; Peter Kellman; Andrew E Arai
Journal:  JACC Cardiovasc Imaging       Date:  2012-06

4.  T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo.

Authors:  Peter Kellman; Anthony H Aletras; Christine Mancini; Elliot R McVeigh; Andrew E Arai
Journal:  Magn Reson Med       Date:  2007-05       Impact factor: 4.668

5.  Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage.

Authors:  Lourens F H J Robbers; Elise S Eerenberg; Paul F A Teunissen; Matthijs F Jansen; Maurits R Hollander; Anton J G Horrevoets; Paul Knaapen; Robin Nijveldt; Martijn W Heymans; Marcel M Levi; Albert C van Rossum; Hans W M Niessen; C Bogdan Marcu; Aernout M Beek; Niels van Royen
Journal:  Eur Heart J       Date:  2013-04-17       Impact factor: 29.983

Review 6.  Myocardial oedema: a preventable cause of reperfusion injury?

Authors:  D Garcia-Dorado; J Oliveras
Journal:  Cardiovasc Res       Date:  1993-09       Impact factor: 10.787

7.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).

Authors:  Borja Ibanez; Stefan James; Stefan Agewall; Manuel J Antunes; Chiara Bucciarelli-Ducci; Héctor Bueno; Alida L P Caforio; Filippo Crea; John A Goudevenos; Sigrun Halvorsen; Gerhard Hindricks; Adnan Kastrati; Mattie J Lenzen; Eva Prescott; Marco Roffi; Marco Valgimigli; Christoph Varenhorst; Pascal Vranckx; Petr Widimský
Journal:  Eur Heart J       Date:  2018-01-07       Impact factor: 29.983

8.  Intramyocardial haemorrhage and prognosis after ST-elevation myocardial infarction.

Authors:  Sebastian J Reinstadler; Thomas Stiermaier; Martin Reindl; Hans-Josef Feistritzer; Georg Fuernau; Charlotte Eitel; Steffen Desch; Gert Klug; Holger Thiele; Bernhard Metzler; Ingo Eitel
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2019-02-01       Impact factor: 6.875

9.  Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI).

Authors:  Daniel R Messroghli; James C Moon; Vanessa M Ferreira; Lars Grosse-Wortmann; Taigang He; Peter Kellman; Julia Mascherbauer; Reza Nezafat; Michael Salerno; Erik B Schelbert; Andrew J Taylor; Richard Thompson; Martin Ugander; Ruud B van Heeswijk; Matthias G Friedrich
Journal:  J Cardiovasc Magn Reson       Date:  2017-10-09       Impact factor: 5.364

10.  T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patients.

Authors:  Heerajnarain Bulluck; Steven K White; Stefania Rosmini; Anish Bhuva; Thomas A Treibel; Marianna Fontana; Amna Abdel-Gadir; Anna Herrey; Charlotte Manisty; Simon M Y Wan; Ashley Groves; Leon Menezes; James C Moon; Derek J Hausenloy
Journal:  J Cardiovasc Magn Reson       Date:  2015-08-12       Impact factor: 5.364

View more
  2 in total

1.  Left atrial adaptation in ischemic heart disease: insights from a cardiovascular magnetic resonance study.

Authors:  Anna Giulia Pavon; Pier Giorgio Masci; Lorenzo Pucci; Antonio Landi; Amit Bermano; Amir Vaxman; Craig Gotsman; Tobias Rutz; Pierre Monney; Rita Godihno; David Saraiva Rodrigues; Olivier Muller; Marco Valgimigli; Juerg Schwitter
Journal:  Int J Cardiovasc Imaging       Date:  2022-02-17       Impact factor: 2.357

Review 2.  T2 mapping in myocardial disease: a comprehensive review.

Authors:  Aaron T O'Brien; Katarzyna E Gil; Juliet Varghese; Orlando P Simonetti; Karolina M Zareba
Journal:  J Cardiovasc Magn Reson       Date:  2022-06-06       Impact factor: 6.903

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.